BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15794407)

  • 1. [Sublingual immunotherapy with allergenic extract of Dermatophagoides pteronyssinus in asthmatic children].
    Rodríguez Santos O
    Rev Alerg Mex; 2004; 51(5):177-80. PubMed ID: 15794407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term efficacy of sublingual immunotherapy with Dermatophagoides Farianae Drops in children with allergic asthma sensitized to dust mites].
    Tian M; Lu YQ; Wang Y; Jiang YH; Zhao DY
    Zhonghua Er Ke Za Zhi; 2013 Oct; 51(10):741-4. PubMed ID: 24406225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sublingual immunotherapy in allergic rhinitis and asthma in 2-5 year-old children sensitized to mites].
    Rodríguez Santos O
    Rev Alerg Mex; 2008; 55(2):71-5. PubMed ID: 19058484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.
    Di Rienzo V; Marcucci F; Puccinelli P; Parmiani S; Frati F; Sensi L; Canonica GW; Passalacqua G
    Clin Exp Allergy; 2003 Feb; 33(2):206-10. PubMed ID: 12580913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.
    Majak P; Rychlik B; Stelmach I
    Clin Exp Allergy; 2009 Dec; 39(12):1830-41. PubMed ID: 19817753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of specific sublingual immunotherapy with dermatophagoides farinae drops in the treatment of cough variant asthma in children].
    Zheng BQ; Wang GL; Yang S
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):585-8. PubMed ID: 22898278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
    Mosbech H; Deckelmann R; de Blay F; Pastorello EA; Trebas-Pietras E; Andres LP; Malcus I; Ljørring C; Canonica GW
    J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands.
    Marogna M; Massolo A; Colombo F; Isella P; Bruno M; Falagiani P
    Allergol Immunopathol (Madr); 2011; 39(2):60-7. PubMed ID: 21216083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus.
    Ibero M; Castillo MJ
    J Investig Allergol Clin Immunol; 2006; 16(3):194-202. PubMed ID: 16784014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
    Maestrelli P; Zanolla L; Pozzan M; Fabbri LM;
    J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
    Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
    Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.